Read by QxMD icon Read

Vaccine HPV

Onyema Greg Chido-Amajuoyi, Joël Fokom Domgue, Chisom Obi-Jeff, Kathleen Schmeler, Sanjay Shete
No abstract text is available yet for this article.
November 30, 2018: Lancet Global Health
Tülin Çataklı, Aysu Duyan-Çamurdan, F Nur Aksakal-Baran, Ahmet Enes Güven, Ufuk Beyazova
Çataklı T, Duyan-Çamurdan A, Aksakal-Baran FN, Güven AE, Beyazova U. Attitudes of physicians concerning vaccines not included in the national immunization schedule. Turk J Pediatr 2018; 60: 290-297. The aim of this study was to identify attitudes of family physicians and pediatricians working in sub-provinces of central Ankara concerning rotavirus (RV), human papilloma virus (HPV), meningococcal conjugate vaccine (MenACWY-MCV4) and adolescent and adult pertussis (Tdap) vaccines which are not included in the National Immunization Schedule (NIS)...
2018: Turkish Journal of Pediatrics
Ngu Dau Bing Michael, Tengku Norina Tuan Jaffar, Adil Hussein, Wan-Hazabbah Wan Hitam
Vaccination-induced optic neuritis is not common. The development of optic neuritis following various vaccinations have been reported, suggesting a possible association between optic neuritis and vaccination. Of those reported cases, influenza vaccines have been the most common. Although rare, those patients who developed optic neuritis following HPV vaccination also presented with other central nervous system (CNS) demyelinating syndromes, especially following a booster dose. We present a rare case of simultaneous isolated bilateral optic neuritis following the first dose of an HPV vaccination in a young child...
September 24, 2018: Curēus
Jason J Ong, Sandra Walker, Andrew Grulich, Jennifer Hoy, Tim R H Read, Catriona Bradshaw, Marcus Chen, Suzanne M Garland, Richard Hillman, David J Templeton, Jane Hocking, Beng Eu, B K Tee, Eric P F Chow, Christopher K Fairley
BACKGROUND: Men who have sex with men (MSM) living with HIV have a high risk of anal cancer. We estimate the likely benefit of HPV vaccination amongst participants of the Anal Cancer Examination (ACE) study. METHODS: Anal swabs were collected for the detection and genotyping of anal HPV DNA by Linear Array (Roche Diagnostics) in this two-year multicentre prospective cohort. We calculated the proportion of men, stratified by age, without detectable vaccine-type-specific DNA...
November 30, 2018: Sexually Transmitted Diseases
Yutaka Ueda, Asami Yagi, Sayaka Ikeda, Takayuki Enomoto, Tadashi Kimura
No abstract text is available yet for this article.
December 2018: Lancet Oncology
Yvonne N Flores, Jorge Salmerón, Beth A Glenn, Cathy M Lang, L Cindy Chang, Roshan Bastani
OBJECTIVE: To compare the knowledge, beliefs, and practices regarding HPV vaccination among mothers of vaccine-eligible girls in Mexico and the USA. METHODS: Similar samples of Mexican mothers with vaccine-eligible daughters were surveyed at two clinics in Cuernavaca, Morelos, from July to October 2012 (n = 200) and at two clinics in Oxnard, California, from August to November 2013 (n = 200). RESULTS: Although mothers in the USA had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the USA (49% vs...
December 1, 2018: International Journal of Public Health
Chanqiong Zhang, Chongan Huang, Xiang Zheng, Dan Pan
Background: Human papillomavirus (HPV) is associated with an increased risk of cervical cancer. Using a vaccine to prevent HPV infections could be a cost-effective strategy to decrease the incidence of cervical cancer. Learning about the characteristics of CIN patients with HPV infection in Wenzhou is a key step in guiding the use of HPV vaccines and screening for cervical cancer. Methods: We undertook a retrospective analysis including 2612 women who were treated in the Department of Gynecology and Obstetrics from Jan 2016 to Nov 2017...
2018: Infectious Agents and Cancer
Anna Hidle, Gwati Gwati, Taiwo Abimbola, Sarah W Pallas, Terri Hyde, Amos Petu, Deborah McFarland, Portia Manangazira
Objective: To determine the cost of Zimbabwe's human papillomavirus (HPV) vaccination demonstration project. Methods: The government of Zimbabwe conducted the project from 2014-2015, delivering two doses of HPV vaccine to 10-year-old girls in two districts. School delivery was the primary vaccination strategy, with health facilities and outreach as secondary strategies. A retrospective cost analysis was conducted from the provider perspective. Financial costs (government expenditure) and economic costs (financial plus the value of existing or donated resources including vaccines) were calculated by activity, per dose and per fully immunized girl...
December 1, 2018: Bulletin of the World Health Organization
Tetsuo Nakayama
Vaccine adverse events and controversial safety issues have occurred in recent decades in Japan: aseptic meningitis following the measles-mumps-rubella combined vaccine (MMR), anaphylaxis after immunization with live virus vaccines and inactivated split influenza vaccine, an increased incidence of febrile illness following the simultaneous administration of inactivated vaccines, and chronic pain with neurological illness after immunization with the human papilloma virus vaccine (HPV). Vaccine adverse events are a matter of concern for the public as well as general practitioners; some are within the range of assumptions that adverse reactions after live attenuated vaccines are related to the nature of their parental wild-type viruses...
November 29, 2018: Vaccine
Hoda Jradi, Amen Bawazir
AIM: To our knowledge there are no studies exploring Saudi women's understanding of the importance of the human papillomavirus (HPV) vaccine. In the present study, we examined the awareness of HPV and women's attitudes toward the HPV vaccine. METHOD: Nine focus groups were formed in Riyadh City, Saudi Arabia, including 77 women between the ages of 18 and 45 years old. Face-to-face interviews were conducted in 58 female healthcare providers to examine women's awareness of cervical cancer, HPV, barriers, acceptance, beliefs, and attitudes towards the HPV vaccine...
November 28, 2018: Vaccine
Mette Tuxen Faber, Anne Katrine Duun-Henriksen, Christian Dehlendorff, Manrinder Kaur Tatla, Christian Munk, Susanne K Kjaer
BACKGROUND: Few studies have studied the association between unintended human papillomavirus (HPV) vaccination and adverse pregnancy outcomes. This study set out to determine the association between HPV vaccination during pregnancy and subsequent risk of spontaneous abortion, stillbirth, and one-year infant mortality. METHODS: Population-based study including all pregnancies in Denmark (October 2006-December 2014) among women born 1975-1992. From nationwide health registries using the personal identification numbers, we obtained information on HPV vaccination, pregnancy outcomes, and infant mortality...
November 28, 2018: Vaccine
Christopher T Haley, Uyen Ngoc Mui, Ramya Vangipuram, Peter L Rady, Stephen K Tyring
In 1964, the first human oncovirus, Epstein-Barr virus (EBV), was identified in Burkitt lymphoma cells. Since then, six other human oncoviruses have been identified: human papillomavirus (HPV), Merkel cell polyomavirus (MCPyV), hepatitis B and C viruses (HBV and HCV), human T-cell lymphotropic virus-1 (HTLV-1), and human herpesvirus-8 (HHV-8). These viruses are causally linked to 12% of all cancers, many of which have mucocutaneous manifestations. Additionally, oncoviruses are associated with multiple benign mucocutaneous diseases...
November 28, 2018: Journal of the American Academy of Dermatology
Uyen Ngoc Mui, Christopher T Haley, Ramya Vangipuram, Stephen K Tyring
In 1964, the first human oncovirus, Epstein-Barr virus (EBV), was identified in Burkitt lymphoma cells. Since then, six other human oncoviruses have been identified: human papillomavirus (HPV), Merkel cell polyomavirus (MCPyV), hepatitis B and C viruses (HBV and HCV), human T-cell lymphotropic virus-1 (HTLV-1), and human herpesvirus-8 (HHV-8). These viruses are causally linked to 12% of all cancers, many of which have mucocutaneous manifestations. Additionally, oncoviruses are associated with many benign mucocutaneous diseases...
November 28, 2018: Journal of the American Academy of Dermatology
A Thirumal Raj, Shankargouda Patil, Archana A Gupta, Chandini Rajkumar, Kamran H Awan
Human papillomavirus is a well-established risk factor for oropharyngeal cancer, although its role in oral cancer is still debated. Inconclusive evidence of its role in oral cancer is due to conflicting data arising from methodological differences, mostly due to the use of diagnostic tests with varying sensitivity and specificity. In addition, there is a lack of experimental data linking HPV to oral cancer. Recent epidemiological studies provide data on HPV prevalence in oral squamous cell carcinoma and other potentially malignant oral disorders...
November 27, 2018: Disease-a-month: DM
Dimitris Kostaras, Eleftheria Karampli, Kostas Athanasakis
INTRODUCTION: During the last years, a significant number economic evaluations of HPV vaccination has been published. Given that cost-effectiveness constitutes an essential part of decision-making with regards to the reimbursement of a health technology, the purpose of this study is to provide a supportive tool to decision-makers regarding the economic efficiency of the introduction of HPV vaccination to national immunization programs. Areas covered: The PubMed database was searched in order to identify cost-effectiveness studies for HPV vaccination...
December 1, 2018: Expert Review of Pharmacoeconomics & Outcomes Research
Laura M Mann, Eloisa Llata, Elaine W Flagg, Jaeyoung Hong, Lenore Asbel, Juli Carlos-Henderson, Roxanne P Kerani, Robert Kohn, Preeti Pathela, Christina Schumacher, Elizabeth A Torrone
Background: Approximately 90% of genital warts are caused by human papillomavirus (HPV) types 6 and 11. In the US, HPV vaccination has been recommended for females ≤26 years; and since 2011, males ≤21 years and gay, bisexual, and other men who have sex with men (MSM) ≤26 years. Methods: Data were obtained from 27 clinics participating in the STD Surveillance Network (SSuN). Trends in the annual prevalence of anogenital warts (AGW) from 2010-2016 were described by sex and sex of sex partners...
November 29, 2018: Journal of Infectious Diseases
Alexis Sims, Elaine Archie-Booker, Reinetta T Waldrop, Mechelle Claridy, Gemechu Gerbi
Background: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US. Methods: Data from the 2014 Behavioral Risk Factor Surveillance System were used to assess predictors of HPV vaccination. A multivariable logistic regression analysis was used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs)...
2018: ARC Journal of Public Health and Community Medicine
Iva Kinkorová Luňáčková, Ondřej Májek
Carcinoma of the uterine cervix belongs to significant malignancy in the Czech Republic. The goal of organized national cervical cancer screening program is to decrease incidence and mortality of this disease. Discovery of casual relationship between human papillomavirus (HPV) and cervical cancer together with modern examinations methods pushed forward possibilities of primary and secondary prevention worldwide. In the article, there are mentioned basic statistical data of cervical cancer screening in the Czech Republic (the annual coverage of the target population, incidence, prevalence, mortality etc...
2018: Ceskoslovenská Patologie
Daniel Grace, Mark Gaspar, Rachelle Paquette, Ron Rosenes, Ann N Burchell, Troy Grennan, Irving E Salit
The human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Gay, bisexual, and other men who have sex with men (GBM) living with HIV are disproportionately impacted by HPV-associated anal cancer, with rates about 100-fold that of the general population. Fortunately, HPV vaccination has proven efficacy in preventing both anogenital warts (condyloma) in males and anal pre-cancers (anal intraepithelial neoplasia; AIN) in GBM up to the age of 26. We conducted in-depth, semi-structured interviews with 25 HIV-positive gay men in Toronto to gain an understanding of their knowledge and experiences related to HPV and the HPV vaccine...
2018: PloS One
M Arbyn, L Xu
Recently, the evidence on efficacy and safety of prophylactic HPV vaccines derived from randomized trials was published in the Cochrane database of Systematic reviews. A summary of this Cochrane review is presented below. Areas covered: Only trials involving mono-, bi-, and quadrivalent HPV vaccines were included. Trials evaluating the nonavalent vaccine were excluded since women in the control group received the quadrivalent vaccine. Main efficacy outcomes were: histologically confirmed cervical precancer lesions distinguishing those associated with vaccine HPV types and any cervical precancer...
November 29, 2018: Expert Review of Vaccines
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"